These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37052145)

  • 1. Stress-related neuropeptide systems as targets for treatment of alcohol addiction: A clinical perspective.
    Heilig M
    J Intern Med; 2023 May; 293(5):559-573. PubMed ID: 37052145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The affective dimension of pain as a risk factor for drug and alcohol addiction.
    LeBlanc DM; McGinn MA; Itoga CA; Edwards S
    Alcohol; 2015 Dec; 49(8):803-9. PubMed ID: 26008713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcoholism and neuropeptides: an update.
    Cowen MS; Lawrence AJ
    CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):233-9. PubMed ID: 16611096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism.
    Valdez GR; Koob GF
    Pharmacol Biochem Behav; 2004 Dec; 79(4):671-89. PubMed ID: 15582675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocircuitry of alcohol addiction: synthesis from animal models.
    Koob GF
    Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of corticotropin-releasing factor in alcohol and nicotine addiction.
    Simpson S; Shankar K; Kimbrough A; George O
    Brain Res; 2020 Aug; 1740():146850. PubMed ID: 32330519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD).
    Rodriguez FD; Coveñas R
    Curr Med Chem; 2017; 24(23):2528-2558. PubMed ID: 28302012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide systems and new treatments for nicotine addiction.
    Bruijnzeel AW
    Psychopharmacology (Berl); 2017 May; 234(9-10):1419-1437. PubMed ID: 28028605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of stress associated with chronic alcohol exposure on drinking.
    Becker HC
    Neuropharmacology; 2017 Aug; 122():115-126. PubMed ID: 28431971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide modulation of addiction: Focus on galanin.
    Genders SG; Scheller KJ; Djouma E
    Neurosci Biobehav Rev; 2020 Mar; 110():133-149. PubMed ID: 29949733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond.
    Ciccocioppo R; Gehlert DR; Ryabinin A; Kaur S; Cippitelli A; Thorsell A; Lê AD; Hipskind PA; Hamdouchi C; Lu J; Hembre EJ; Cramer J; Song M; McKinzie D; Morin M; Economidou D; Stopponi S; Cannella N; Braconi S; Kallupi M; de Guglielmo G; Massi M; George DT; Gilman J; Hersh J; Tauscher JT; Hunt SP; Hommer D; Heilig M
    Alcohol; 2009 Nov; 43(7):491-8. PubMed ID: 19913192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of alcohol dependence with drug antagonists of the stress response.
    Higley AE; Koob GF; Mason BJ
    Alcohol Res; 2012; 34(4):516-21. PubMed ID: 23584117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropharmacology of alcohol addiction.
    Vengeliene V; Bilbao A; Molander A; Spanagel R
    Br J Pharmacol; 2008 May; 154(2):299-315. PubMed ID: 18311194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.
    Lowery EG; Thiele TE
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):77-86. PubMed ID: 20201818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
    Heilig M; Egli M
    Pharmacol Ther; 2006 Sep; 111(3):855-76. PubMed ID: 16545872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin releasing factor: a key role in the neurobiology of addiction.
    Zorrilla EP; Logrip ML; Koob GF
    Front Neuroendocrinol; 2014 Apr; 35(2):234-44. PubMed ID: 24456850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcoholism: allostasis and beyond.
    Koob GF
    Alcohol Clin Exp Res; 2003 Feb; 27(2):232-43. PubMed ID: 12605072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic neuropeptide signaling in alcohol addiction.
    Barson JR; Leibowitz SF
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():321-9. PubMed ID: 25689818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic mechanisms of alcoholism and stress-related disorders.
    Palmisano M; Pandey SC
    Alcohol; 2017 May; 60():7-18. PubMed ID: 28477725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
    Koob GF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.